Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy Response

被引：1
|
作者：
Sayed, Ahmed [1 ]
Munir, Malak [1 ]
Poliner, Michael [2 ]
Sughra, Sana [2 ]
Epperla, Narendranath [3 ]
Addison, Daniel [4 ,5 ]
机构：
[1] Ain Shams Univ, Fac Med, Cairo, Egypt
[2] Ohio State Univ, Med Ctr, Columbus, OH USA
[3] Ohio State Univ, Columbus, OH USA
[4] Ohio State Univ, Cardiooncol Program, Div Cardiol, Med Ctr, Columbus, OH USA
[5] Ohio State Univ, James Canc Hosp, Div Canc Control & Prevent, Columbus, OH 43210 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2024年 / 12卷 / 04期
关键词：
T cell; ONCOLOGY; FOOD;
D O I：
10.1136/jitc-2024-009300
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Immune-related adverse events with bispecific T-cell engager therapy targeting B-cell maturation antigen
    Piron, Benedicte
    Bastien, Mathilde
    Antier, Chloe
    Dalla-Torre, Romain
    Jamet, Bastien
    Gastinne, Thomas
    Dubruille, Viviane
    Moreau, Philippe
    Martin, Jerome
    Benichou, Antoine
    Touzeau, Cyrille
    Tessoulin, Benoit
    HAEMATOLOGICA, 2024, 109 (01) : 357 - 361
  • [32] Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager
    Yang, Zhuo
    Hou, Yingqin
    Grande, Geramie
    Cho, Jong Hyun
    Wang, Chao
    Shi, Yujie
    Zak, Jaroslav
    Wan, Yue
    Qin, Ke
    Liu, Dongfang
    Teijaro, John R.
    Lerner, Richard A.
    Wu, Peng
    NATURE BIOMEDICAL ENGINEERING, 2024, 8 (05) : 499 - 512
  • [33] A novel bispecific T-cell engager for targeting ROR1 positive malignancies
    Gohil, S. H.
    Moscosso, S. R. Paredes
    Harrasser, M.
    Sorio, C.
    Davidoff, A. M.
    Nathwani, A. C.
    Della Peruta, M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A60 - A60
  • [34] Targeting the tumor stroma with a bispecific T-cell engager-armed oncolytic adenovirus
    de Sostoa Pomes, J.
    Fajardo, C. A.
    Moreno, R.
    Ramon, M. D.
    Farrera Sal, M.
    Alemany, R.
    ANNALS OF ONCOLOGY, 2018, 29 : 34 - 34
  • [35] Environmental sustainability assessment as a driver for selection of the manufacturing processes of a bispecific T-cell engager
    Gabriela, Monica
    Smith, Benjamin T.
    Connors, Bart
    Leslie, Marc
    Hartwick, Adam
    Gant, Kevin
    Faul, Margaret M.
    REACTION CHEMISTRY & ENGINEERING, 2024, 9 (10): : 2773 - 2783
  • [36] Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy
    Yang, Xiao-mei
    Lin, Xuan-dong
    Shi, Wei
    Xie, Shen-xia
    Huang, Xia-ning
    Yin, Shi-hua
    Jiang, Xiao-bing
    Hammock, Bruce D.
    Xu, Zhi Ping
    Lu, Xiao-ling
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [37] The landscape of bispecific T cell engager in cancer treatment
    Zhou, Shujie
    Liu, Mingguo
    Ren, Fei
    Meng, Xiangjiao
    Yu, Jinming
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [38] Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy
    Xiao-mei Yang
    Xuan-dong Lin
    Wei Shi
    Shen-xia Xie
    Xia-ning Huang
    Shi-hua Yin
    Xiao-bing Jiang
    Bruce D. Hammock
    Zhi Ping Xu
    Xiao-ling Lu
    Signal Transduction and Targeted Therapy, 8
  • [39] Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model
    Selvaggio, Gianluca
    Parolo, Silvia
    Bora, Pranami
    Leonardelli, Lorena
    Harrold, John
    Mehta, Khamir
    Rock, Dan A.
    Marchetti, Luca
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Neurological toxicities associated with chimeric antigen receptor T-cell therapy
    Rubin, Daniel B.
    Danish, Husain H.
    Ali, Ali Basil
    Li, Karen
    LaRose, Sarah
    Monk, Andrew D.
    Cote, David J.
    Spendley, Lauren
    Kim, Angela H.
    Robertson, Matthew S.
    Torre, Matthew
    Smith, Timothy R.
    Izzy, Saef
    Jacobson, Caron A.
    Lee, Jong Woo
    Vaitkevicius, Henrikas
    BRAIN, 2019, 142 : 1334 - 1348
12345